INTRODUCTIONTransplant renal artery stenosis (TRAS) is the main vascular complication of renal transplant, responsible for at least 75% of the cases. Although often asymptomatic and underdiagnosed, it is responsible for 1–5% of the resistant hypertension cases and the leading cause of graft dysfunction and premature death of the receiver .TRAS has widely varying prevalence in the literature, from 1 to 23% , due to different factors: the expansion in the use of noninvasive diagnostic methods as a screening tool, the differences in anastomosis techniques and graft preservation and also the absence of clear standardization of diagnostic criteria, especially regarding the definition of hemodynamically significant disease.Angiography remains as gold standard for TRAS diagnosis. However, the precise correlation between the hemodynamic repercussion and the severity of stenosis measured remains under evaluation, with a great heterogeneity in the values used as threshold for surgical or percutaneous revascularization .Fractional flow reserve (FFR) is the method of choice for the evaluation of the hemodynamic repercussion of epicardial stenosis in patients with coronary artery disease. Its use in candidate selection for myocardial revascularization is associated with a significant reduction in the incidence of cardiovascular events and costs . More recent studies have indicated that the
Catheterization and Cardiovascular Interventions – Wiley
Published: Jan 1, 2018
Keywords: ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera